Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0024530 (malaria)
 44,886 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Even though tsetse control measures were discontinued in the Lambwe Valley in 1974 the prevalence of Rhodesian sleeping sickness remained at low levels. A survey conducted in 1978 verified a low prevalence of disease (0.1%). Thirty-four per cent of the individuals tested were positive for malaria with the highest prevalence (44%) in children aged 0-9 years. Thirteen of 1340 individuals (0.97%) tested and found negative for sleeping sickness in 1978 developed the disease by 1985. Fourteen individuals with moderate titres (2+) in the IFAT but who showed no evidence of disease were traced and found to be alive and well seven years later. Three of these patients still had positive titres but the others had converted to negative. Sera from four patients infected and treated in 1978 were also positive, but only one of five patients treated in 1977 reacted in the test. The CFT as described did not appear useful as a diagnostic test.
 ...
PMID:Sleeping sickness in the Lambwe Valley in 1978. 269 85

In primary Rhodesian sleeping sickness patients, parasitological diagnosis was best performed by rodent inoculation of blood (98.5%+) followed by Giemsa-stained thick blood smears (93.3%+). Parasitological diagnosis in relapse patients was sometimes impossible and clinical diagnosis based on CSF examination was necessary. Early during a disease outbreak in 1980, 89% of the infections were detected by mobile field teams, but once established in the endemic area a stationary diagnostic facility detected most of the cases. A total number of 23,751 examinations for Rhodesian sleeping sickness and malaria were made by mobile field teams during 1980-1984; 102 primary cases (0.43%) and 25 (0.10%) relapse cases were diagnosed. A total of 9339 individuals (39%) had patent malaria infections. The IFAT was positive in 89% of the primary sleeping sickness patients and 77% of the relapse patients. Seventy-nine per cent of the primary patients were positive in a CFT test, and 77% of the relapse patients were considered positive.
 ...
PMID:Diagnosis of Rhodesian sleeping sickness in the Lambwe Valley (1980-1984). 269 86

A rapid and economical micro-counterimmunoelectrophoresis (MCIE) test, for antibody to trypanosome antigens, has been developed which may prove useful in trypanosomiasis surveillance. MCIE was more sensitive and more rapid than immunodiffusion (ID). Serum samples from trypanosome-infected rabbits and cattle (Nigerian and Gambian), from Kuwaiti dogs and camels, from Ivory Coast sleeping sickness patients, from Brazilian patients with Chagas's disease, plus mouse-anti-malaria sera have been tested by MCIE with Trypanosoma brucei, T. vivax, T. congolense and T. cruzi antigens. A few of the rabbit and the mice sera were also tested against Trichomonas vaginalis, Entamoeba histolytica, Plasmodium berghei or P. chabaudi antigens. Whenever possible the MCIE results were compared with parasitological or other serological tests (ID; indirect fluorescent antibody test, IFAT; enzyme-linked immunosorbent assay, ELISA; complement fixation test, CFT or indirect haemagglutination test, IHAT). The MCIE test was not species specific but the homologous species reactions were more often positive than heterologous ones. Homologous species reactions, with rabbit sera, detected antibodies as early as 10 days after infection and developed more precipitin lines as the infection progressed. Trypanosomal antigens and antisera cross-reacted with those of other protozoa (E. histolytica, Tr. vaginalis, P. chabaudi, P. berghei, and Babesia sp. and Leishmania sp.) but such reactions required an antigen concentration 4 to 16 times greater than that required for homologous trypanosome reactions (a factor which might be exploited for identification of different species of trypanosome).(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:Micro-counterimmunoelectrophoresis: a rapid screening technique for trypanosomiasis. 641 74